Gallbladder Cancer - Obesity Reviews, Recent Papers, and Clinical Trials
To see the 1 Review, go directly to PubMed.
REVIEWS from PubMed – November 12. 2023 – Obesity (in title) AND Cancer (in title) AND Gallbladder AND Review
- Association between obesity and gallbladder cancer June 2, 2012Obesity has become a global health issue because of its increased morbidity and mortality, and a close association with at least 20 different cancers. Clinical and epidemiological studies have suggested that obesity and overweight are positively related with the risk of GBC. Gallbladder cancer (GBC) is a relatively infrequent but highly lethal neoplasm. Obesity may […]Fei Wang
To see all 3 Papers, go directly to PubMed.
RECENT PAPERS from PubMed – November 12. 2023 – Obesity (in title) AND Cancer (in title) AND gallbladder (in title)
- Association between obesity and gallbladder cancer June 2, 2012Obesity has become a global health issue because of its increased morbidity and mortality, and a close association with at least 20 different cancers. Clinical and epidemiological studies have suggested that obesity and overweight are positively related with the risk of GBC. Gallbladder cancer (GBC) is a relatively infrequent but highly lethal neoplasm. Obesity may […]Fei Wang
- Obesity and the risk of gallbladder cancer: a meta-analysis March 22, 2007We performed a meta-analysis of studies of the association between excess body weight and risk of gallbladder cancer identified from MEDLINE and EMBASE databases from 1966 to February 2007 and the references of retrieved articles. A random-effects model was used to combine results from eight cohort studies and three case-control studies, with a total of […]S C Larsson
- Pituitary obesity associated with abnormalities of the kidneys and adrenal glands and cancer of the gallbladder July 1, 1975No abstractE F Zaremba
Clinical Trials involving Gallbladder Cancer and Obesity
NCT Number | Study Title | Study URL | Acronym | Study Status | Interventions | Sponsor | Collaborators | Enrollment | Study Type | Locations |
---|---|---|---|---|---|---|---|---|---|---|
NCT04633512 | Safety and Feasibility of ActivSightTM in Human | https://clinicaltrials.gov/study/NCT04633512 | ENROLLING_BY_INVITATION | DEVICE: ActivSight | Activ Surgical | The University of Texas Health Science Center, Houston|University at Buffalo|Ohio State University | 67 | INTERVENTIONAL | Kaleida Health, University of Buffalo, Buffalo, New York, 14203, United States|Memorial Hermann Texas Medical Center, Houston, Texas, 77030, United States|Memorial Hermann Sugar Land Hospital, Sugar Land, Texas, 77479, United States | |
NCT04534309 | Behavioral Weight Loss Program for Cancer Survivors in Maryland | https://clinicaltrials.gov/study/NCT04534309 | ASPIRE | COMPLETED | BEHAVIORAL: Written Weight Loss Material|BEHAVIORAL: Weight Loss App|BEHAVIORAL: Behavioral Lifestyle Weight Loss Intervention (Coaching) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Maryland Cigarette Restitution Fund | 340 | INTERVENTIONAL | Johns Hopkins ProHealth, Baltimore, Maryland, 21207, United States |
NCT05579444 | Systems Biology of Gastrointestinal and Related Diseases | https://clinicaltrials.gov/study/NCT05579444 | RECRUITING | Viome | 100000 | OBSERVATIONAL | Viome Life Sciences, Bothell, Washington, 98011, United States |